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Abstract 
 
Objectives: There is a paucity of data regarding the reliability of using non-invasive monitors 
in pregnancy. The aim of this study was to compare hemodynamic measurements obtained 
by non-invasive methods, against those obtained by 2-dimensional transthoracic 
echocardiography. 
 
Methods: We recruited a total of 114 healthy pregnant and postpartum women who had 
cardiac output (CO) estimations obtained by two non-invasive devices as well as 2-D 
transthoracic echocardiography (TTE). The non-invasive devices employed in this cross 
comparison study were USCOM® (continuous wave Doppler analysis of trans-aortic blood 
flow) and NICOM® (thoracic bioreactance). Accuracy and precision statistics were presented 
as bias, precision, 95% limits of agreement (LOA) and mean percentage difference (MPD).  
 
Results: USCOM® had a bias ranging from 0.4-0.9L/min. The mean percentage difference 
of USCOM® was 28% in the third trimester cohort.  NICOM® had a bias ranging from -0.9 
L/min to 0.6L/min with a mean percentage difference of 32% in the third trimester group. We 
observed no agreement between the non-invasive devices and TTE in the first and second 
trimesters - we found an MPD of 38% for USCOM in both the first and second trimesters, 
and an MPD of 70% and 61% for NICOM in the first and second trimesters, respectively. We 
found excellent repeatability (ICC = 0.969, 95% CI 0.953-0.980) and reproducibility (ICC= 
0.896, 95% CI 0.812-0.944) for USCOM®, and comparable repeatability for NICOM® (ICC = 
0.953, 95% CI 0.927-0.969).  
 
Conclusion: We have demonstrated good agreement between USCOM® and NICOM® 
when compared against 2-d transthoracic echocardiography, specifically in the third 
trimester of pregnancy. Our findings suggest that both devices have good intraobserver 
repeatability/ interobserver reproducibility and can be utilised by healthcare professionals of 
different levels of experience. Future studies should take into account the significant 
differences in the precise maternal hemodynamic values obtained by these devices, and 
consider developing device-specific reference ranges in pregnancy and the postpartum 
period. 
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Introduction  
Pregnancy is associated with significant changes in maternal hemodynamics, which 
increases as gestation advances. In pathological conditions these changes can be even 
more profound and are of increased clinical significance both during and following pregnancy 
(1-4).  In routine clinical practice, reliance is placed on maternal heart rate and brachial blood 
pressure as surrogate markers to provide information on cardiac indices such as maternal 
stroke volume (SV) and cardiac output (CO). Despite being relatively crude, these proxy 
markers are routinely used to guide clinical management, cardiovascular resuscitation and 
restore hemodynamic homeostasis. In previous decades, changes in maternal 
hemodynamics were investigated using dye dilution techniques (5) and pulmonary artery 
catheterization (PAC)  (6). CO measurement with a PAC using the bolus thermodilution 
method has become the gold standard and the reference method to compare novel, non-
invasive technologies against (7, 8). Such invasive techniques would be undesirable in 
current obstetric practice due to significant risk of complications such as infection, vascular 
injury and cardiac arrhythmias. Furthermore, validation of non-invasive methods in the 
obstetric population against such invasive techniques would also not be practically or 
ethically feasible. Transthoracic echocardiography (TTE) is a widely accepted methodology 
for CO estimation in pregnancy due to its non-invasive nature and absence of ionising 
radiation; its use in expectant mothers is considered entirely safe and acceptable. TTE has 
been validated in pregnancy against thermodilution and dye dilution techniques, and has 
been reported to be an accurate method for CO estimation (9, 10). However, access to TTE 
in labor requires both costly equipment and clinical expertise, thereby limiting availability. 
 
 More recently, a plethora of non-invasive cardiac monitors have become readily available 
for clinical use, providing an opportunity to accurately assess maternal hemodynamic status 
in the peripartum period. Two such commercially available devices are the ultrasound 
cardiac output monitor (USCOM®, USCOM Ltd, Australia) and NICOM® (Non-Invasive 
Cardiac Output Monitor, Cheetah Medical, USA) which use continuous-wave Doppler and 
thoracic bioreactance analyses, respectively, to estimate hemodynamic indices in simple-to-
use platforms. USCOM® is an operator-dependant device which is potentially subject to 
inter- and intra-observer variation.  Proficient use of this device is associated with an 
individual learning curve, and a requirement to attend a training session and carry out 
approximately 30 test cases before being able to obtain data for clinical or research 
purposes. As obtaining a haemodynamic profile using USCOM® requires access to the 
suprasternal notch (and some extension of the subjects neck), it is not practically feasible to 
provide continuous haemodynamic evaluation (eg intraoperatively) or intrapartum. NICOM® 
is entirely operator-independent and therefore not subject to inter-observer variation. 
NICOM® electrodes can be placed on the thorax and continuous haemodynamic variables 
can be obtained twice a minute, and can therefore be utilised during an operative procedure 
(eg caesarean section) with minimal disruption to the patient or the medical team caring for 
the patient.  A drawback of NICOM® is the ongoing cost of consumables (skin surface 
electrodes).   
 
 
The aim of this study was to compare hemodynamic measurements obtained by these 
different non-invasive methods against those obtained by 2-dimensional TTE. 
 
 
Methods 
Pregnant women aged 16 and over with healthy, singleton pregnancies were recruited from 
various (booking, scanning and routine antenatal) clinics at our tertiary center. Women from 
three, discrete gestational age groups were recruited in each trimester. In the postnatal 
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group, all study participants were recruited within 72 hours of delivery. Women receiving 
antihypertensive medication, with a known history of congenital / acquired heart disease or 
an incidental finding of a structural abnormality on echocardiogram were excluded. Women 
who had a pulse rate over 100bpm or a mean arterial pressure greater than 125mmHg were 
excluded. Written consent was obtained from all study participants and local research ethics 
committee approval (12/LO/0810) was sought prior to data collection. The study obstetrician 
examined all women and both maternal and fetal wellbeing were confirmed prior to obtaining 
any measurements.  
 
All non-invasive and echocardiographic studies were performed in the same room, under 
standardised conditions by the same operators for the entire cohort. A single operator, 
following a 5-minute period of inactivity, obtained non-invasive measurements 
simultaneously. Both assessors were blinded to each other’s recordings. Patients less than 
24 weeks (ie those in the first and second trimester groups) were in a semi-recumbent 
position, and those in the third trimester were assessed in a left lateral position in order to 
avoid aortacaval compression by the gravid uterus. 
 
USCOM®  
The ultrasound cardiac output monitor (USCOM®, USCOM Ltd, Australia) employs 
continuous wave Doppler, with a non-imaging probe in the suprasternal notch to obtain 
velocity time integrals (VTI) of transaortic or transpulmonary blood flow at the left or right 
ventricular outflow tract respectively. Using an anthropometric algorithm, which correlates 
the outflow tract diameter with the patient’s given height, USCOM® uses the VTIs to compute 
SV, CO and a complete hemodynamic profile. USCOM® tracings were obtained in flowtracer 
mode (automated tracing of each Doppler profile), and a single operator analyzed all 
images, and excluded poor quality Doppler profiles. Each acquisition used for analysis had a 
minimum of 2 consecutive Doppler profiles (figure 1). The operator received formal training 
in the use of USCOM and performed over 50 measurements prior to recruiting patients to 
this study.  
 
Intraobserver repeatability of USCOM® was assessed by each patient having two separate, 
consecutive Doppler acquisitions obtained within 5 minutes of one another. Interobserver 
reproducibility of USCOM® was assessed by two operators. Doppler acquisitions were 
obtained within 10 minutes of each other. Both operators were blinded to one another’s 
recordings. All repeatability and reproducibility studies were performed in pregnant study 
participants (not in the postnatal cohort). The second operator is a research midwife who 
received informal training by the study investigator (DV), formal training by an USCOM® 
representative and carried out the recommended 30 cases prior to collecting data used for 
reproducibility analysis.  
 
NICOM®  
The Non-Invasive Cardiac Output Monitor, NICOM® (Cheetah Medical, USA) uses thoracic 
bioreactance technology which is based on analysis of thoracic voltage amplitude changes 
in response to a high-frequency injected current. The NICOM® device analyses the 
variations in frequency spectra (relative phase shifts) after delivering a transthoracic 
alternating current and uses several assumptions (about thoracic shape and fluid volumes) 
and algorithms, to compute SV, CO and an array of hemodynamic parameters. NICOM® 
surface electrodes were placed on participants (posterior aspect of the thorax) prior to them 
lying supine / left lateral position, and readings were obtained simultaneously to USCOM® 
readings. Following calibration, two separate complete sets of data were collected for each 
patient. The first set of data was used for comparison analysis; the second was used for 
repeatability analysis.  
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TTE 
Two-dimensional transthoracic echocardiography views were obtained by a single, qualified 
(adult and paediatric/fetal) cardiac sonographer using a GE Vivid E9 (GE Healthcare, Little 
Chalfont, UK) with a single crystal phased array M5Sc transducer. Participants were 
scanned in the left lateral position and multiple recordings of three views were obtained 
(parasternal long axis, apical four-chamber, and apical five-chamber views). Three-lead 
electrocardiogram was used in order to enable image gating. Analysis was performed using 
dedicated analysis software (EchoPAC, GE Healthcare, Little Chalfont, UK). All 
measurements were performed according to recommendations from the American Society of 
Echocardiography (11). 
 
After cardiac structural normality was confirmed, two methods of cardiac output estimation 
were employed in this study. The results presented are from comparison to the first method 
described. Comparison statistics with the latter method are provided in the supplementary 
material.  
1. Left ventricular outflow tract cross sectional area – velocity time integral (LVOT CSA – 
VTI) method determines the SV as a product of the LVOT cross-sectional area and LVOT 
velocity time integral obtained by pulsed wave (PW) Doppler. The diameter of LVOT was 
measured in the parasternal long axis view, at the level of the aortic valve (AV) annulus in 
early systole (figure 2). The measurement was obtained from the inner edge to the inner 
edge of the aortic cusp insertion. Due to the inherent error of the tomographic plane to 
underestimate the annulus diameter, we obtained 3-5 recordings of the AV dimensions, and 
then an average value was used in subsequent calculations.  Assuming a circular shape of 
the LVOT, the area of the LVOT was calculated using the formula CSA = 0.785 x D2.  
 
Measurements of the LVOT VTI were obtained from the apical five-chamber view. A pulsed 
wave Doppler sample was positioned at the center of LVOT, 3-5mm proximal to the aortic 
valve (figure 3). If the AV opening click was present in the Doppler recording, the sample 
volume was withdrawn slightly into the outflow tract. The sample volume length was 2-5mm 
in order to narrow the spectral broadening of the PW signal. Care was taken to ensure that 
the ultrasound beam was parallel to the blood flow in the LVOT. Multiple PW Doppler 
recordings were obtained in order to avoid underestimation of the LVOT velocities. The 
LVOT VTI envelope was traced along the leading velocity (outer edge of the densest 
envelope) with at least 3-4 beats measured and averaged. The SV was calculated as a 
product of VTI multiplied by CSA of the LVOT (Figure 3). Heart rate (HR) was obtained by 
measuring the R-R interval using the ECG and then by multiplying the R-R interval by 60. 
CO for both methods was calculated using the formula: CO = SV x HR. 
 
2. Single-plane Simpson rule - Left ventricular end diastolic volume (LVEDV) and end 
systolic volume (LVESV) were automatically calculated by tracing the endocardial border in 
diastole and systole in the apical four-chamber view respectively (figures 1 and 2, 
supplementary material). Volumes were automatically calculated by mathematically dividing 
the ventricle along its long axis into a series of discs of equal height. The ventricular volume 
is then represented by the sum of the volume of each of the discs. The ventricular SV was 
calculated as SV = LVEDV - LVESV.  
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Statistical analysis 
All statistical analysis was carried out using IBM SPSS Statistics version 21. The Shapiro-
Wilk test for normality was performed on all data sets to assess distribution. The correlation 
coefficients, in order to assess the linear relationship between the two methods, are 
expressed as either Pearson’s (normally distributed data) or Spearman’s (non-normally 
distributed data). The accuracy and precision statistics provided include bias (mean 
difference between two methods), precision (standard deviation of differences), 95% limits of 
agreement (bias +/- 1.96 SD) and mean percentage difference (MPD) (LOA / mean between 
two methodologies). Bland-Altman plots are provided in the supplementary material (figures 
3-18).  
 
Intraobserver repeatability and interobserver reproducibility are expressed as an intra-class 
correlation coefficient (ICC) with 95% confidence intervals (95% CI). A two-way mixed 
effects model was used when calculating the intra-class correlation coefficients. 
 
A mean percentage difference of 30% between two methodologies for cardiac output 
estimation has been proposed to be a level of clinical acceptability (7). 
 
 
Results 
A total of 114 participants were recruited to the study between January and October 2015 
(Figure 4). Following exclusions, a total of 98 datasets across the four groups were 
analyzed. We excluded 5 cases of echocardiographic assessment due to poor views – 
predominantly in women in the third trimester and with raised body mass index (BMI). We 
also deemed 2 USCOM® Doppler acquisitions as unsuitable for analysis – this was because 
both acquisitions (upon quality control, prior to analysis) were not felt to represent the VTI 
obtained at the aortic valve. We did not have any failure to obtain haemodynamic variables 
using NICOM® in the study cohort. All patients had measurements obtained by both non-
invasive monitors and echocardiography. Table 1 shows the basic demographic data of the 
entire study cohort.  
 
Heart Rate  
Heart rate correlation between the non-invasive monitors and echocardiography was strong 
(USCOM® r=0.866, p<0.01; NICOM® r=0.846, p<0.01). The HR correlation between the two 
monitors was also strong (r=0.920, p<0.01). Comparison between USCOM® and 
echocardiography showed a bias of 0.3bpm, precision of 7bpm with 95% limits of 
agreements of -13 to +14bpm and a MPD of 17%.  Comparison between NICOM® and 
echocardiography revealed similar agreement with a bias of 0.5bpm, precision of 7 bpm and 
95% limits of agreements of -14 to +15 bpm and a MPD of 17%. When compared to each 
other, the HR analysis of both non-invasive devices demonstrated a bias of -0.9bpm, 
precision of 4bpm with 95% limits of agreements of -9 to +7 bpm and a MPD of 10%.  
 
Stroke Volume  
Comparison between USCOM® and echocardiography showed a moderate correlation 
(r=0.330, p<0.05).  Further analysis demonstrated a bias of 11.4mls, precision of 16.4mls, 
95% limits of agreement from -20 to +43mls and a MPD of 45%. Comparison between 
NICOM® and echocardiography showed a weak correlation (r=0.272, p<0.05). Further 
analysis revealed a bias of -1.9mls, precision of 19.9mls, 95% limits of agreement from -40.8 
to 36.9mls and a MPD of 60%.  
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Cardiac Output 
The correlation coefficients and precision analyses for USCOM® and for NICOM® in each 
trimester and in the postpartum group are presented in tables 2 and 3, respectively.  
Figures 5 and 6 demonstrate the positive and negative bias of each non-invasive 
methodology when compared to TTE CO estimates. USCOM® exhibits a largely positive 
bias, which is evident in the majority of patients at lower TTE CO estimates. However 
NICOM® did not demonstrate such skewed bias, and indeed the proportion of readings with 
positive and negative bias appears similar, irrespective of low or high TTE CO estimates. 
The variation in bias of NICOM® we found, goes someway to explaining the wide limits of 
agreement.  
 
Repeatability and Reproducibility  
Intraobserver repeatability assessment was performed in 67 subjects. Three USCOM® 
Doppler acquisitions of acceptable quality were obtained for intraobserver repeatability 
assessment. The intra-class correlation coefficient for USCOM® CO estimation was 0.969 
(95% CI 0.953-0.980). Each patient had two, complete NICOM® profiles obtained. The intra-
class correlation coefficient for NICOM® CO estimation was 0.953 (95% CI 0.927-0.969). 
The interobserver reproducibility of USCOM® was assessed in 40 subjects, across the three 
trimesters. This varied from 0.899 (95% CI 0.790-0.952) in the first trimester (27 cases), 
0.969 (95% CI 0.88-0.992) in the second trimester (10 cases), and 0.965 (95% CI 0.185-
0.990) in the third trimester (3 cases). The intra-class correlation coefficient for CO was 
0.896 (95% CI 0.812-0.944). As NICOM® is a user-independent device, interobserver 
reproducibility was not assessed. 
 
Discussion  
USCOM® and NICOM® demonstrated good agreement with echocardiography in the third 
trimester. The level of agreement between USCOM® and echocardiography in the third 
trimester meets the recommended level of clinical acceptability (7). The MPD for USCOM® 
ranged from 28.8% (third trimester) to 43.8% (postpartum). MPD at earlier gestations was 
38%, comparable to previously published data in non-pregnant patients (12). NICOM® has 
near clinically acceptable agreement in the third trimester (MPD of 32%), however we found 
no agreement outside of the third trimester.  
 
 
Interpretation of study findings and comparison with the existing literature 
 
A meta-analysis (12) of USCOM® validation studies outside of pregnancy reported a mean 
bias of -0.39 L/min, precision of 1.27L/min, 95% LOA of -2.879 L/min and +2.099 L/min with 
a MPD of 42.7% (see Table 4 for a summary of validation studies). In one study (13) 
comparing USCOM® to 3-dimensional TTE in advanced pregnancy, the authors reported a 
bias of +0.4L/min, precision of 1.0 L/min, 95% LOA of -1.4 L/min to +2.3 L/min and a MPD of 
31.4%, comparable to the findings in our study. The level of agreement in the current study 
was higher than previously reported in the non-obstetric population.  
 
NICOM® in the third trimester has a MPD approaching 30% and therefore shows potential to 
be used intrapartum and at advanced gestations.  NICOM® has many positive attributes, 
including its simplicity of use, operator-independence and ability to provide continuous 
hemodynamic profiles in an intra-operative/intrapartum situation. The levels of agreement we 
observed would indicate that NICOM® cannot be used interchangeably with 
echocardiography at earlier gestations or postnatally. Several NICOM® validation studies 
(Table 4) display highly variable levels of accuracy and precision. Early validation studies 
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reported strong correlations (r=0.84-0.90) between bioreactance and pulmonary artery 
catheterization derived CO estimates (14), however Bland Altman analysis was lacking.  
Importantly, the differences between the different techniques are acceptable as long as 
different technology-specific reference ranges are employed. 
 
 
Study strengths and limitations  
 
The cross sectional area used to deduce stroke volume is obtained by different 
methodologies. The strength of using echocardiography is that the LVOT is measured in 
individual patients. USCOM® employs an algorithm, based only on patient’s height, to 
provide the outflow tract diameter. Measurement of flow in the region of the aortic annulus as 
performed by TTE provides the highest accuracy (15, 16). Whilst the USCOM® estimation 
provides an easy and reproducible method enabling its bedside application, it does not factor 
in weight or body surface area (BSA), thus representing a potential source of error in CO 
estimation. Pregnancy is associated with significant changes in BSA, and this could be 
associated with changes in aortic dilatation (17-19).  
 
Echocardiography and USCOM® utilize different Doppler modalities. PW Doppler enables a 
recording of velocity at any specific point within the cardiac anatomy, unlike continuous wave 
(CW) Doppler, which cannot ascertain the precise location at which that velocity was 
obtained. Training in the correct application of USCOM® is important in order to obtain the 
transaortic VTI. Inaccurate recordings (eg in the ascending aorta) can be a significant source 
of error.  
 
Finally, it is plausible that the hyperdynamic circulation will result in greater noise artefact, 
which will be included in the USCOM® CW Doppler spectrum. This may result in “over-
reading” of the VTI, and hence produce a falsely elevated CO estimation than that provided 
by PW Doppler techniques. This may potentially explain the positive bias in the obstetric 
population, as compared to the negative bias reported in the non-obstetric population.  
 
 
 
Clinical / Research Implications 
 
Our data demonstrate that USCOM® and NICOM® show good agreement at advanced 
gestations.  In clinical practice, their application will be in the management of critical illness 
in advanced pregnancy (eg septic shock, hemorrhage or preeclampsia).  Both technologies 
have favorable characteristics that make them suitable for bedside application. They are 
simple to use with measurements obtained in minutes, by both medical and non-medical 
personnel (20) with minimal training required to achieve operative proficiency.  
 
This cross comparison study, and the results we have found at earlier gestations, does pose 
a question about the accuracy and precision of non-invasive monitors, and the interpretation 
of their findings, when used outside of the third trimester, hence thorough validation must be 
performed prior to interpreting published maternal hemodynamics data. Importantly, the 
indices obtained using non-invasive devices will not be directly comparable to those of TTE 
and hence device-specific reference ranges need to be constructed. One of the most 
relevant applications of this technology will be to display trends in haemodynamics. The 
inherent assumptions made by the machine algorithms should be of little relevance when 
assessing trends within a patient, as the “error” is likely to remain constant. Future studies 
should evaluate the ability of these devices to accurately assess hemodynamic trends in 
both routine and pathological obstetric cases.  
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Conclusion 
There is an unquestionable need for non-invasive hemodynamic monitoring in the 
management of the critically ill obstetric patients and for goal-directed therapy. However, the 
need and desire to utilize non-invasive technology should not be compromised by poorly 
reproducible, inaccurate or unvalidated measurements. Our findings suggest that both 
USCOM® and NICOM® perform well in advanced pregnancy and have excellent repeatability 
and reproducibility.  
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Figure Legends  
Figure 1 USCOM® (UltraSound Cardiac Output Monitor, USCOM Ltd, Australia) 
acquisition from a study participant demonstrating the Doppler profile of transaortic blood 
flow. Doppler profiles with a red envelope (flowtracer) were analysed having been deemed 
acceptable by the study investigator. 
Figure 2 2-d transthoracic echocardiographic measurement of the left ventricular outflow 
tract (LVOT) diameter in the parasternal long axis view, at the level of the aortic valve (AV) 
annulus in early systole. In this example, the LVOT was measured at 1.8cm, which would 
give a cross sectional area (CSA) of 2.54cm2. The CSA is calculated by the formula: CSA = 
0.785 x (LVOT)2. 
Figure 3 Measurements of the left ventricular outflow tract velocity-time integral (LVOT VTI) 
were obtained from the apical five-chamber view. A pulsed wave (PW) Doppler sample was 
positioned at the centre of LVOT, 3-5mm proximal to the aortic valve. VTI x CSA = Stroke 
volume.  
Figure 4 Recruitment flowchart 
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 Eligible patients invited to participate (n=256) 
• Declined to participate (n= 132) 
• Unable to gain valid informed consent due to language barrier (n= 8 ) 
• Measurements not obtained as fetus found to be non-viable (n= 2) 
 
Women recruited and underwent both echocardiography and non-
invasive haemodynamic cardiac output measurements (n=114) 
 
Excluded cases:  
• Poor quality USCOM® Doppler profiles (n=2) 
• Poor quality echo images (n=5) 
• Receiving β-blocker therapy (n=2) 
• Tachycardia  (heart rate >100bpm) / mean arterial pressure >125 (n=6) 
• Cardiac anomaly detected on echocardiogram (n=1) 
 
Participants included in analyses (n=98) 
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 First 
Trimester 
(n=29) 
Second 
Trimester 
(n=25) 
Third 
Trimester 
(n=21) 
Postpartum 
(n=23) 
Maternal Age / years (SD) 31 (6.3) 33 (3.5) 34 (5.5) 30 (5.1) 
Nulliparity, n (%) 18 (62%) 23 (92%) 7 (33%) n/a 
Caucasian, n (%) 22 (76%) 21 (84%) 18 (86%) 13 (56%) 
Maternal weight at booking (kg), 
mean (SD) 
65.3 (9.6) 68.6 (14) 70.4 (14) 71.2 (15.9) 
Maternal BMI at booking (kg/m
2
), 
mean (SD) 
23.1 (5.7) 24.3 (7.3) 26.3 (5.3) 26.4 (5.4) 
Maternal mean arterial pressure at 
booking (mmHg), mean  (SD) 
83 (18) 85 (8) 93 (20) 86 (10) 
Maternal weight at assessment (kg), 
mean (SD) 
65.5 (10) 74.5 (15) 85.4 (13.3) 76.6 (16) 
Maternal BMI at assessment 
(kg/m
2
), mean (SD) 
24.2 (3.8) 27.3 (5.5) 31.9 (4.9) 28.3 (5.3) 
Maternal mean arterial pressure at 
assessment (mmHg), mean  (SD) 
85 (19) 84.3 (9) 96.7 (8) 89 (14) 
 
 
Table 1 Baseline characteristics of the study cohort  
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 First Trimester Second Trimester Third Trimester Postpartum 
USCOM®  0.366 0.364 0.569* 0.176 
NICOM®  0.048 -0.086 0.664* 0.610* 
 
Table 2 Correlation coefficients for NICOM® (Non-Invasive Cardiac Output Monitor, NICOM® 
(Cheetah Medical, USA) and USCOM® (UltraSound Cardiac Output Monitor, USCOM Ltd, 
Australia)  vs echocardiography (LVOT-VTI method) for each study group. Correlation 
coefficients that reached statistical significance (p<0.05) are highlighted (*). 
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 First 
Trimester 
Second 
Trimester 
Third 
Trimester 
Postpartum 
Bias (L/min)     USCOM® 0.738 0.896 0.861 0.439 
Precision (L/min) 1.041 1.091 0.788 1.357 
95% LOA (L/min) -1.304 
+2.779 
-1.242 
+3.034 
-0.683 
+2.407 
-2.221 
+3.099 
MPD (%) 38.1 38.1 28.8 43.8 
Bias (L/min)    NICOM® -0.97 -0.354 0.581 -0.009 
Precision (L/min) 1.61 1.555 0.857 1.319 
95% LOA 
(L/min) 
-4.12 
+2.18 
-3.403 
+2.696 
-1.099 
+2.261 
-2.593 
+2.575 
MPD (%) 70.6 61 32.2 44.1 
 
Table 3 Accuracy and precision statistics for USCOM® (UltraSound Cardiac Output Monitor, 
USCOM Ltd, Australia) and NICOM® (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) vs 2d transthoracic echocardiography (TTE) using the left ventricular outflow 
tract – velocity time integral (LVOT-VTI)  method for cardiac output (CO) estimation. Bias = 
mean difference between two methodologies, precision = standard deviation of the bias, 
95% limits of agreement (LOA) = bias ± 1.96 SD, Mean percentage difference (MPD) = 
LOA/mean CO between two methodologies x 100.   
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Table 4 A summary of accuracy and precision statistics from a selection of published validation studies of both USCOM® (UltraSound Cardiac Output 
Monitor, USCOM Ltd, Australia) and NICOM® (Non-Invasive Cardiac Output Monitor, Cheetah Medical, USA) in the non-obstetric population. Only 
studies which reported on complete accuracy and precision statistics (and not just correlation coefficients) are included. The two NICOM® studies reported 
cardiac index (L/min/m
2
) instead of cardiac output (L/min). 
 
Investigators Year Patient 
Population  
Reference 
Method  
Non 
Invasive 
Device 
used  
Bias  
(L/min or 
L/min/m
2
) 
Precision 
(L/min or 
L/min/m
2
) 
95% Limits 
of 
Agreement 
(L/min or 
L/min/m
2
) 
Mean 
Percentage 
Difference 
(%) 
Knirsch 2008 Paediatric 
Cardiology 
PAC Thermodilution  USCOM® -0.13 1.34 -1.47 
+1.21 
36.4 
Tan 2005 ICU PAC Thermodilution 
 
USCOM® -0.18 0.82 -1.43 
+1.78 
35.7 
Thom  2009 ICU PAC Thermodilution USCOM®  -0.09 1.47 -3.01 
+2.83 
51.7 
Wong  2008 Liver 
transplant 
PAC Thermodilution USCOM® -0.39 0.93 -1.47 
+2.25 
25.6 
Kober 
 
2013 Cytoreductive 
surgery in 
ovarian 
carcinoma 
PAC Thermodilution NICOM® 0.26 0.85 -1.39 
+1.92 
50.7 
Kupersztych-
Hagege 
 
2013 ITU PAC Thermodilution NICOM® -0.09 2.55 -2.2 
+4.1 
82 
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 First 
Trimester 
Second 
Trimester 
Third 
Trimester 
Postpartum 
Bias (L/min)     USCOM® 0.916 1.051 0.7401 0.488 
Precision (L/min) 0.863 1.158 0.790 1.322 
95% LOA (L/min) -0.775 
+2.607 
-1.218 
+3.321 
-0.808 
+2.288 
-2.103 
+3.079 
MPD (%) 32 39.7 29.8 45.5 
Bias (L/min)    NICOM® -0.801 -0.200 0.458 0.010 
Precision (L/min) 1.561 1.408 0.887 1.305 
95% LOA 
(L/min) 
-3.861 
+2.259 
-2.966 
+2.560 
-1.281 
+2.197 
-2.548 
+2.568 
MPD (%) 69.8 54.2 33.2 43.7 
 
 
Table 1 Supplementary Material 
 Accuracy and precision statistics for USCOM® (UltraSound Cardiac Output Monitor, USCOM 
Ltd, Australia) and NICOM® (Non-Invasive Cardiac Output Monitor, Cheetah Medical, USA) 
vs 2d transthoracic echocardiography (TTE) using the single-plane Simpson’s method for 
cardiac output (CO) estimation. This method involves deducing ventricular volumes by 
tracing the endocardial border in diastole and systole in the apical four-chamber view.  Bias = mean 
difference between two methodologies, precision = standard deviation of the difference, 
95% limits of agreement (LOA) = bias ± 1.96 SD, Mean percentage difference (MPD) = 
LOA/mean CO between two methodologies x 100. 
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 1
st
 Trimester 2
nd
 Trimester 3
rd
 Trimester 
NICOM vs Echo 
(LVOT-VTI) 
-0.139 -0.188 0.575* 
USCOM vs Echo 
(LVOT-VTI) 
0. 406* 0.158 0.552* 
 
Table 2 Supplementary Material 
For all pregnant patients, we calculated the body surface area (BSA) using the weight and height 
obtained at assessment. The LVOT-VTI cardiac output was indexed using the BSA obtained, to 
deduce a cardiac index (L/min/m
2
). Table 2 gives the correlation coefficients for NICOM® (Non-
Invasive Cardiac Output Monitor, Cheetah Medical, USA) and USCOM® (UltraSound Cardiac Output 
Monitor, USCOM Ltd, Australia) vs TTE cardiac index (CI) estimates for each trimester. Correlation 
coefficients that reached statistical significance (p<0.05) are highlighted (*).  
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 1st Trimester 2nd Trimester 3rd Trimester 
Bias (L/min/m2)     USCOM® 0.388 0.570 0.517 
Precision (L/min/m2) 0.590 0.754 0.462 
95% LOA (L/min/m
2
) -0.769 
+1.546 
-0.909 
+2.050 
-0.387 
+1.422 
MPD (%) 36.8 45.6 32.1 
Bias (L/min/m
2
)    NICOM® -0.630 -0.157 0.256 
Precision (L/min/m2) 0.976 0.894 0.465 
95% LOA 
(L/min/m2) 
-2.543 
+1.282 
-1.910 
+1.596 
-0.655 
+1.167 
MPD (%) 72.9 61.2 33.9 
 
Table 3 supplementary material  
For all pregnant patients, we calculated the body surface area (BSA) using the weight and height 
obtained at assessment. The LVOT-VTI cardiac output was indexed using the BSA obtained, to 
deduce a cardiac index (L/min/m
2
). Table 3 shows the accuracy and precision statistics for cardiac 
index agreement between NICOM® (Non-Invasive Cardiac Output Monitor, Cheetah Medical, USA) 
and USCOM® (UltraSound Cardiac Output Monitor, USCOM Ltd, Australia).  
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Fig 1 (Supplementary material) Bland Altman Plot demonstrating the mean bias and 95% limits of 
agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah Medical, 
USA) and transthoracic echo (TTE) CO estimates obtained by the left ventricular outflow 
tract – velocity time integral (LVOT-VTI) method in the first trimester.  
 
Figure 2 (supplementary material)  Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the left ventricular 
outflow tract – velocity time integral (LVOT-VTI) method in the second trimester.  
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Figure 3 (supplementary material)  Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the left ventricular 
outflow tract – velocity time integral (LVOT-VTI) method in the third trimester. 
 
Figure 4 (supplementary material)  Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the left ventricular 
outflow tract – velocity time integral (LVOT-VTI) method in the postpartum group. 
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Figure 5 (supplementary material) Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the single-plane 
Simpson rule, in the first trimester.  
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Figure 6 (supplementary material) Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the single-plane 
Simpson rule, in the second trimester.  
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Figure 7 (supplementary material) Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the single-plane 
Simpson rule, in the third trimester. 
Page 28 of 39
John Wiley & Sons, Ltd.
Ultrasound in Obstetrics and Gynecology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
Figure 8 (supplementary material) Bland Altman Plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between NICOM
®
 (Non-Invasive Cardiac Output Monitor, Cheetah 
Medical, USA) and transthoracic echo (TTE) CO estimates obtained by the single-plane 
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Simpson rule, in the postpartum group. 
 
 
Figure 9 (Supplementary material) Bland Altman plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the left ventricular outflow 
tract – velocity time integral (LVOT-VTI) method, in the first trimester.  
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Figure 10 (Supplementary material) Bland Altman plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the left ventricular outflow 
tract – velocity time integral (LVOT-VTI) method, in the second trimester.  
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Figure 11 (Supplementary material) Bland Altman plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the left ventricular outflow 
tract – velocity time integral (LVOT-VTI) method, in the third trimester.  
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Figure 12 (Supplementary material) Bland Altman plot demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the left ventricular outflow 
tract – velocity time integral (LVOT-VTI) method, in the postpartum group.  
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Figure 13 (Supplementary material) Bland Altman Plots demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the single-plane Simpson 
rule, in the first trimester.  
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Figure 14 (Supplementary material) Bland Altman Plots demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the single-plane Simpson 
rule, in the second trimester. 
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Figure 15 (Supplementary material) Bland Altman Plots demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the single-plane Simpson 
rule, in the third trimester. 
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Figure 16 (Supplementary material) Bland Altman Plots demonstrating the mean bias and 95% limits 
of agreement (LOA) between USCOM
 ®
 (Ultrasound Cardiac Output Monitor, USCOM Ltd, 
Australia) and transthoracic echo (TTE) CO estimates obtained by the single-plane Simpson 
rule, in the postpartum group. 
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Figure 17 (supplementary material) Left ventricular end diastolic volume (LVEDV) was automatically calculated by tracing the endocardial border in diastole in the 
apical four-chamber view. In this example, the LVEDV was 101.98 mls. The single-plane Simpson’s method involves mathematically dividing the ventricle along its 
long axis into a series of discs of equal height. The ventricular volume is then represented by the sum of the volume of each of the discs. 
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Figure 18 (supplementary material) Left ventricular end systolic volume (LVESV) was automatically calculated by tracing the endocardial border in systole in the 
apical four-chamber view. In this example, the LVESV was 18.51 mls. The stroke volume is deduced by LVEDV – LVESV; in the examples shown, the stroke volume 
would be equivalent to 83.47 mls. 
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